Teva secures FDA approval for Ajovy injection in migraine prevention

pharmanewsdaily- September 16, 2018 0

Teva Pharmaceutical Industries has achieved a significant regulatory milestone with the U.S. Food and Drug Administration (FDA) approving Ajovy (fremanezumab-vfrm) injection for migraine prevention in ... Read More